Mert Aktar - 21 Oct 2024 Form 4 Insider Report for Kyverna Therapeutics, Inc. (KYTX)

Role
Director
Signature
By: /s/ Samantha Eldredge, as Attorney-in-Fact
Issuer symbol
KYTX
Transactions as of
21 Oct 2024
Net transactions value
$0
Form type
4
Filing time
24 Oct 2024, 06:05:19 UTC
Next filing
02 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KYTX Stock Option (right to buy) Award $0 +87,741 $0.000000 87,741 21 Oct 2024 Common Stock 87,741 $5.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36th of the shares subject to the option shall vest on each monthly anniversary, such that 100% of the shares subject to the option shall be fully vested and exercisable on the third anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.